NGM Biopharmaceuticals, Inc.
COMBINATION THERAPY WITH GLUCAGON RECEPTOR ANTAGONISTS
Last updated:
Abstract:
The present disclosure provides methods comprising a glucagon receptor antagonist in combination with an immunotherapeutic agent for treatment of disease.
Status:
Application
Type:
Utility
Filling date:
17 Feb 2021
Issue date:
16 Sep 2021